(Q95275857)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32426209%20AND%20SRC:MED&resulttype=core&format=json

24 May 2020

case report

0 references

title

Are Type 1 Interferons treatment in Multiple Sclerosis as a potential therapy against COVID-19? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32426209%20AND%20SRC:MED&resulttype=core&format=json

24 May 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32426209%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

Mehmet Davutoglu

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32426209%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

author name string

Ese Ece Ozdemir

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32426209%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

Abdulsamet Erden

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32426209%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

publication date

16 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32426209%20AND%20SRC:MED&resulttype=core&format=json

24 May 2020

page(s)

102196

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32426209%20AND%20SRC:MED&resulttype=core&format=json

An Italian programme for COVID-19 infection in multiple sclerosis

27 May 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7228888

Weak Induction of Interferon Expression by SARS-CoV-2 Supports Clinical Trials of Interferon Lambda to Treat Early COVID-19

10 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7228888

Type 1 interferons as a potential treatment against COVID-19

10 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7228888

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

10 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7228888

Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV

10 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7228888

10.1016/J.MSARD.2020.102196

10 February 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32426209%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

27 May 2020

COVIDWHO ID

covidwho-276697

0 references

1127630521

1 reference

Dimensions COVID-19 publications, datasets and clinical trials

DOI

10.6084/M9.FIGSHARE.11961063

28 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32426209%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32426209%20AND%20SRC:MED&resulttype=core&format=json